Enzo Biochem - Dividend History | ENZ
Historical dividend payout and yield for Enzo Biochem (ENZ) since 2026. The current TTM dividend payout for Enzo Biochem (ENZ) as of November 19, 2024 is $0.40. The current dividend yield for Enzo Biochem as of November 19, 2024 is 39.60%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.053B |
$0.032B |
|
Enzo Biochem, Inc. develops, manufactures and markets health care products based on molecular biology and genetic engineering techniques, and also provides diagnostic services to the medical community. The business activities of the company are performed by one of the company's three wholly-owned subsidiaries--Enzo Diagnostics, Inc., Enzo Therapeutics, Inc., and Enzo Clinical Labs, Inc. The primary focus of the company's research is the development of products based on two technology platforms -- genetic modulation and immune modulation.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
